Catalyst Wire Dossier Catalyst Wire Dossier

Motexafin Lutetium

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Motexafin Lutetium, covering 2013-01-16 to 2013-01-16. Get the full timeline:

Most recent: Clinical Trial Update: EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer [NA]

See pricing